NCT00657527View on ClinicalTrials.gov

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

December 31, 2002

Conditions
Myocardial IschaemiaCoronary Artery Disease
Interventions
DRUG

Rosuvastatin

BEHAVIORAL

Cholesterol lowering diet

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY